- Home
- JRSH vs APLT Comparison
JRSH vs APLT Comparison
Compare JRSH & APLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JRSH
- APLT
- Stock Information
- Founded
- JRSH 2016
- APLT 2016
- Country
- JRSH United States
- APLT United States
- Employees
- JRSH N/A
- APLT N/A
- Industry
- JRSH Apparel
- APLT Biotechnology: Pharmaceutical Preparations
- Sector
- JRSH Consumer Discretionary
- APLT Health Care
- Exchange
- JRSH Nasdaq
- APLT Nasdaq
- Market Cap
- JRSH 41.2M
- APLT 44.0M
- IPO Year
- JRSH 2018
- APLT 2019
- Fundamental
- Price
- JRSH $3.32
- APLT $0.39
- Analyst Decision
- JRSH Strong Buy
- APLT Buy
- Analyst Count
- JRSH 1
- APLT 7
- Target Price
- JRSH $4.00
- APLT $6.10
- AVG Volume (30 Days)
- JRSH 39.3K
- APLT 2.4M
- Earning Date
- JRSH 08-12-2025
- APLT 08-06-2025
- Dividend Yield
- JRSH 6.03%
- APLT N/A
- EPS Growth
- JRSH N/A
- APLT N/A
- EPS
- JRSH N/A
- APLT N/A
- Revenue
- JRSH $145,812,006.00
- APLT $265,000.00
- Revenue This Year
- JRSH $13.06
- APLT $1,768.13
- Revenue Next Year
- JRSH $10.57
- APLT $292.85
- P/E Ratio
- JRSH N/A
- APLT N/A
- Revenue Growth
- JRSH 24.43
- APLT N/A
- 52 Week Low
- JRSH $2.68
- APLT $0.30
- 52 Week High
- JRSH $4.17
- APLT $10.62
- Technical
- Relative Strength Index (RSI)
- JRSH 54.87
- APLT 51.68
- Support Level
- JRSH $3.25
- APLT $0.32
- Resistance Level
- JRSH $3.33
- APLT $0.36
- Average True Range (ATR)
- JRSH 0.11
- APLT 0.03
- MACD
- JRSH -0.00
- APLT 0.00
- Stochastic Oscillator
- JRSH 69.51
- APLT 73.78
About JRSH Jerash Holdings (US) Inc.
Jerash Holdings (US) Inc along with its subsidiaries is a manufacturer and exporter of customized, ready-made sport and outerwear from knitted fabric from its production facilities in Jordan. The company manufactures for retailers namely Walmart, Costco, Sears, Hanes, Columbia, Land's End, VF Corporation, and Philip-Van Heusen which owns brands such as The North Face, Nautica, Timberland, Wrangler, Lee, Jansport, Calvin Klein, Tommy Hilfiger, IZOD, Speedo etc. It derives its revenue from the manufacturing and sales of outerwear in the United States. The company's product offering consists of jackets, polo shirts, crew neck shirts, pants, and shorts made from knitted fabric. Geographically, the company generates maximum revenue from the United States.
About APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.